{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-009093","form_type":"8-K","ticker":"KALA","cik":"0001479419","company_name":"KALA BIO, Inc.","filed_at":"2024-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.599433+00:00","generated_at":"2026-06-01T04:49:07.058831+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"KALA BIO stockholders elect three Class I directors, approve say-on-pay and auditor ratification","bullets":["Marjan Farid, Andrew Koven, Gregory Perry elected as Class I directors for three-year terms.","Advisory vote on executive compensation approved with 764,305 votes for, 225,459 against.","Ratification of Deloitte & Touche LLP as auditor for FY2024 approved (1,825,140 for, 21,748 against).","Proposal to issue common stock upon conversion of Series E/F/G preferred stock approved (691,010 for, 49,921 against).","Three proposals to increase beneficial ownership limits on Series E/F/G preferred stock did not pass."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-009093","json":"https://secwatch.observer/filing/0001558370-24-009093.json","markdown":"https://secwatch.observer/filing/0001558370-24-009093.md","text":"https://secwatch.observer/filing/0001558370-24-009093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000155837024009093/0001558370-24-009093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000155837024009093/kala-20240611x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:49:07.058831+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}